Alebund Pharmaceuticals (Jiangsu) Limited (HKG:9637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
28.80
+0.30 (1.05%)
At close: Sep 4, 2026

HKG:9637 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Net Income
-750.04-326.03
Depreciation & Amortization
44.6112.52
Other Amortization
0.130.03
Loss (Gain) From Sale of Assets
0.10
Loss (Gain) From Sale of Investments
-1.95-
Loss (Gain) on Equity Investments
2.82-0
Stock-Based Compensation
260.7621.9
Other Operating Activities
108.6616.02
Change in Accounts Receivable
0.87-0.87
Change in Inventory
-4.15-6.12
Change in Accounts Payable
74.064.13
Change in Unearned Revenue
9.0230.77
Change in Other Net Operating Assets
-32.78-2.26
Operating Cash Flow
-287.89-249.9
Operating Cash Flow Growth
--

Investing Activities

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Capital Expenditures
-101.62-230.63
Sale (Purchase) of Intangibles
--6.04
Investment in Securities
-148.38-13.55
Other Investing Activities
13.18-7.2
Investing Cash Flow
-236.82-257.41

Financing Activities

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Short-Term Debt Issued
-32.55
Long-Term Debt Issued
145.03384.62
Total Debt Issued
145.03417.18
Short-Term Debt Repaid
--528.83
Long-Term Debt Repaid
-118.05-57.21
Total Debt Repaid
-118.05-586.03
Net Debt Issued (Repaid)
26.97-168.86
Issuance of Common Stock
535.781,345
Other Financing Activities
-21.04-388.19
Financing Cash Flow
541.72787.67

Net Cash Flow

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Foreign Exchange Rate Adjustments
-2.450.26
Net Cash Flow
14.56280.62

Free Cash Flow

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Free Cash Flow
-389.51-480.52
Free Cash Flow Growth
--
Free Cash Flow Margin
-1274.74%-7364.34%
Free Cash Flow Per Share
-1.59-1.77
Levered Free Cash Flow
-1,950-
Unlevered Free Cash Flow
-1,881-

Additional Metrics

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Cash Interest Paid
18.9914.57
Change in Working Capital
47.0225.66